CEROW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CINGW
Should you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.
CERo Therapeutics (NASDAQ:CEROW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking.
In the previous week, CERo Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
CERo Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
CERo Therapeutics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.
Get CERo Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CEROW vs. The Competition
CERo Therapeutics Competitors List
Related Companies and Tools
